Calumet Specialty Products AI Stock Analysis
Want to see CLMT full AI Analyst Report?
Calumet Specialty Products (CLMT) AI Stock Analysis
Calumet Specialty Products
(NASDAQ:CLMT)
Overall score reflects high fundamental risk despite improving operating momentum: strong recent cash flow is offset by ongoing losses and a severely negative equity position. Technicals also weigh on the score due to bearish trend and weak momentum. Offsetting these, the latest earnings call provided a notably constructive outlook with strong EBITDA performance, meaningful deleveraging progress, and specific, scaled SAF expansion targets.
Calumet Specialty Products (CLMT) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $2.80B
- Dividend Yield
- ―
- Average Volume (3M)
- 1.46M
- Price to Earnings (P/E)
- -14.2
- Beta (1Y)
- 0.75
- Revenue Growth
- 28.37%
- EPS Growth
- -407.11%
- Country
- US
- Employees
- 1,540
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Calumet Specialty Products Business Overview & Revenue Model
Company Description
Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. T...
How the Company Makes Money
Calumet makes money by processing crude oil and other hydrocarbon feedstocks in its refining and specialty production facilities and selling the resulting products at market-based prices. Its earnings are generally driven by (a) the margin between in...
Calumet Specialty Products Earnings Call Summary
The call was strongly positive, driven by record adjusted EBITDA, exceptional Specialty Products and Solutions margins, record Montana Renewables performance, substantial debt reduction, lower leverage, successful completion of the Shreveport turnaround, and a substantially less capital-intensive MaxSAF expansion. The principal challenges were Performance Brands' EBITDA decline from higher input costs and pricing lag, catalyst damage and reduced Montana Renewables rates, temporary turnaround and tie-in downtime, and the possibility that current specialty margins will gradually moderate as global capacity and inventories are restored.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management expects Montana Renewables to reach an 80 million annual gallon SAF run rate by year end, 120 million plus by spring, 120 to 150 million by the end of 2027, and ultimately, to 200 million gallons in 2028, while increasing throughput to 17 thousand barrels a day throughout the project. Specialty sales volumes of 20 thousand barrels a day are viewed as a floor, and after the Shreveport turnaround production is expected to move from the mid forties of thousands barrels a day to the fifties of thousands barrels a day making its own feedstock. Specialty margins are expected to remain pretty similar here for the foreseeable future; the company is not calling for $150 million of SPS to be the new norm forever, does not see a decline in the near future, and said what it did here is pretty reasonable to look at going forward, excluding the Shreveport turnaround and seasonality. The Shreveport turnaround and Montana Renewables and CMR tie in are each expected to take a little bit less than a month, while CMR is expected to generate positive EBITDA going forward, though not as much as it was operating at a full refinery. Calumet plans to continue using cash generated across all businesses to reduce the remaining $175 million of 2028 notes and the 2029 notes callable at par in January of 27.
Calumet Specialty Products Financial Statement Overview
Summary
Mixed fundamentals: revenue is rebounding (+13.2% TTM) and cash generation is strong (TTM operating cash flow $341.1M; free cash flow $265.1M), but profitability remains weak with a sizable TTM net loss (-$193.8M) and the balance sheet is highly strained with deeply negative equity (~-$870.7M TTM), which elevates financial risk.
Income Statement
44NeutralBalance Sheet
24NegativeCash Flow
67Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.20B | 4.14B | 4.19B | 4.18B | 4.69B | 3.15B |
| Gross Profit | 471.00M | 245.70M | 230.80M | 451.70M | 351.70M | 142.90M |
| EBITDA | -39.00M | 238.40M | 164.50M | 418.20M | 104.30M | -1.40M |
| Net Income | -193.80M | -33.80M | -222.00M | 48.10M | -169.80M | -254.90M |
Balance Sheet | ||||||
| Total Assets | 2.99B | 2.69B | 2.76B | 2.75B | 2.74B | 2.13B |
| Cash, Cash Equivalents and Short-Term Investments | 225.20M | 125.10M | 38.10M | 7.90M | 35.20M | 38.10M |
| Total Debt | 2.17B | 2.46B | 2.37B | 2.19B | 1.89B | 1.76B |
| Total Liabilities | 3.60B | 3.18B | 3.22B | 3.00B | 3.03B | 2.51B |
| Stockholders Equity | -870.70M | -732.70M | -712.80M | -491.60M | -533.60M | -388.90M |
Cash Flow | ||||||
| Free Cash Flow | 265.10M | 56.60M | -123.10M | -286.70M | -435.60M | -126.90M |
| Operating Cash Flow | 341.10M | 108.90M | -46.40M | -14.90M | 100.60M | -44.00M |
| Investing Cash Flow | -76.50M | 44.10M | -76.70M | -271.80M | -286.00M | -82.80M |
| Financing Cash Flow | -179.40M | 6.20M | 154.30M | 266.20M | 98.70M | 139.30M |
Calumet Specialty Products Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLMT, the sentiment is Negative. The current price of 31.82 is below the 20-day moving average (MA) of 43.17, below the 50-day MA of 50.99, and below the 200-day MA of 39.56, indicating a bearish trend. The MACD of -5.46 indicates Positive momentum. The RSI at 20.44 is Positive, neither overbought nor oversold. The STOCH value of 4.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLMT.
Calumet Specialty Products Risk Analysis
Calumet Specialty Products disclosed 46 risk factors in its most recent earnings report. Calumet Specialty Products reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksCalumet Specialty Products Peers Comparison
Overall Rating
IOSP72Outperform
EMN65Neutral
LYB65Neutral
CLMT49Neutral
NGVT48Neutral
KOP42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $1.92B | 13.73 | 10.42% | 2.38% | 4.73% | ― | |
| 65Neutral | $7.13B | 11.01 | 10.63% | 5.39% | 0.40% | -6.58% | |
| 65Neutral | $19.62B | 15.26 | 12.39% | 5.67% | -1.80% | ― | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 49Neutral | $2.80B | -14.18 | 20.49% | ― | 28.37% | -407.11% | |
| 48Neutral | $2.00B | 33.58 | 134.01% | ― | -11.62% | ― | |
| 42Neutral | $551.86M | -5.82 | -20.07% | 1.19% | -0.85% | -693.89% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CLMT | Calumet Specialty Products | 31.82 | 13.12 | 70.16% | |
| EMN | Eastman Chemical Company | 62.30 | 7.60 | 13.89% | |
| IOSP | Innospec | 78.01 | 8.80 | 12.71% | |
| KOP | Koppers | 29.36 | 1.87 | 6.82% | |
| LYB | Lyondellbasell Industries | 60.69 | 20.46 | 50.88% | |
| NGVT | Ingevity | 59.28 | 10.77 | 22.20% |
Calumet Specialty Products Corporate Events
Calumet Specialty Boosts Credit Facility, Enhancing Liquidity
PositiveOn September 11, 2026, Calumet, Inc. entered into an Eleventh Amendment to its Third Amended and Restated Credit Agreement, boosting lender commitments from $500 million to $600 million, subject to borrowing base limits. The larger facility enhances...
Montana Renewables Unveils Capital-Efficient SAF Expansion Plan
PositiveOn August 28, 2026, Montana Renewables and the U.S. Department of Energy amended their existing loan guarantee agreement to reflect a redesigned, more capital‑efficient expansion of the Great Falls renewable fuels facility. The project shifts from a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
